Skip to main content
. 2018 Dec 17;21(5):606–615. doi: 10.1093/neuonc/noy187

Table 2.

Patient demographics and clinical characteristics

Pathology Tumor Tissue Dx Plasma MV Analysis
# Sex Age Treatment Prior to Blood Draw Diagnosis EGFR EGFRvIII IDH1-R132H EGFR EGFRvIII IDH1-R132H
G1 M 49 None GB mesench Amp NA WT Pos Pos Neg
G2 F 75 None GB proneural Polysomy Chr7 NA WT Pos Neg Neg
G3 M 73 None GB proneural Neg Neg WT Neg Neg Neg
G4 F 63 None GB proneural Amp Neg WT Pos Neg Neg
G5 M 55 Surgery + XRT + TMZ GB mesench Amp Neg WT Pos Neg Neg
G6 M 61 Surgery + XRT + TMZ GB mesench Amp Neg WT Pos Neg Neg
G7 M 73 Surgery + XRT + TMZ GB NA Amp NA WT Pos Neg Neg
G8 F 54 Surgery + XRT + TMZ GB mesench Neg Neg WT Neg Neg Neg
H1 M 57 None Normal NA NA NA NA NA NA
H2 M 50 None Normal NA NA NA NA NA NA

XRT = external beam radiation therapy; TMZ = temozolomide; WT = wildtype. The plasma MV analysis was largely concordant with pathological analysis of tumor tissue, although some specimens were small biopsies only. NA = not available.